Rxelite Stock Today
| RXEI Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 87
|
RxElite is trading at 1.0E-4 as of the 22nd of December 2024. This is a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. RxElite has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 22nd of November 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd. Rxelite operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. More on RxElite
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
RxElite Stock Highlights
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RxElite (RXEI) is traded on OTCCE Exchange in USA and employs 47 people. RxElite is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 35.91 K. RxElite conducts business under Pharmaceuticals sector and is part of Health Care industry.
RxElite currently holds about 1.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check RxElite Probability Of Bankruptcy
RxElite Stock Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RxElite. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more detail on how to invest in RxElite Stock please use our How to Invest in RxElite guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RxElite. If investors know RxElite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RxElite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.096 | Quarterly Revenue Growth 3.321 | Return On Assets (0.38) | Return On Equity (2.94) |
The market value of RxElite is measured differently than its book value, which is the value of RxElite that is recorded on the company's balance sheet. Investors also form their own opinion of RxElite's value that differs from its market value or its book value, called intrinsic value, which is RxElite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RxElite's market value can be influenced by many factors that don't directly affect RxElite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RxElite's value and its price as these two are different measures arrived at by different means. Investors typically determine if RxElite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RxElite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.